When do minority drug-resistant HIV-1 variants have a major clinical impact?

J Infect Dis. 2010 Mar;201(5):647-9. doi: 10.1086/650545.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Drug Resistance, Viral*
  • Genetic Variation
  • HIV Infections / drug therapy*
  • HIV Infections / virology*
  • HIV-1 / classification*
  • HIV-1 / genetics*
  • HIV-1 / growth & development
  • HIV-1 / isolation & purification
  • Humans
  • Mutation, Missense*
  • Selection, Genetic

Substances

  • Anti-HIV Agents